Different effects of rosiglitazone and metformin on adipose tissue glucose uptake in type 2 diabetes

被引：0
|
作者：
Yuan, MS
Melendez, PA
Iwamoto, M
Lee, JS
Shoelson, SE
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
585
引用
收藏
页码：A145 / A145
页数：1
相关论文
共 50 条
  • [31] Metabolic effects of rosiglitazone and metformin in Greek patients with recently diagnosed type 2 diabetes
    Iliadis, Fotios
    Kadoglou, Nikolaos P.
    Hatzitolios, Apostolos
    Karamouzis, Michalis
    Alevizos, Miltiadis
    Karamitsos, Dimitrios
    IN VIVO, 2007, 21 (06): : 1107 - 1114
  • [32] The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus
    Jung, HS
    Youn, BS
    Cho, YM
    Yu, KY
    Park, HJ
    Shin, CS
    Kim, SY
    Lee, HK
    Park, KS
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (03): : 314 - 320
  • [33] Effects of initial use of half-maximal dose rosiglitazone-metformin combination therapy, compared with maximum dose rosiglitazone or metformin, on glucose metabolism in type 2 diabetes mellitus
    Choe, Charles
    Christiansen, Louis
    Edelman, Steven
    Mudaliar, Sunder
    Henry, Robert R.
    DIABETES, 2006, 55 : A107 - A107
  • [34] Rosiglitazone selectively increases subcutaneous but not visceral adipose tissue mass in type 2 diabetes mellitus
    Banerji, M
    Lebovitz, H
    Dugbartey, M
    DIABETES, 2001, 50 : A90 - A90
  • [35] Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes
    Hällsten, K
    Virtanen, KA
    Lönnqvist, F
    Sipilä, H
    Oksanen, A
    Viljanen, T
    Rönnemaa, T
    Viikari, J
    Knuuti, J
    Nuutila, P
    DIABETES, 2002, 51 (12) : 3479 - 3485
  • [36] Oxygen uptake in subcutaneous adipose tissue in type 2 diabetes: relation to perfusion and insulin-mediated glucose uptake and response to exercise
    Bucci, M.
    Virtanen, K. A.
    Viljanen, A.
    Honka, M. J.
    Landini, L.
    Oikonen, V.
    Ferrannini, E.
    Nuutila, P.
    Iozzo, P.
    DIABETOLOGIA, 2016, 59 : S289 - S289
  • [37] Comparative effects of rosiglitazone and metformin on fatty liver and visceral adiposity in Type 2 diabetes mellitus
    Kelley, DE
    McKolanis, TM
    Kelley, CA
    DIABETOLOGIA, 2002, 45 : A188 - A188
  • [38] Comparative effects of rosiglitazone and metformin on fatty liver and visceral adiposity in type 2 diabetes mellitus
    Kelley, DE
    Mckolanis, TM
    Kelley, CA
    DIABETES, 2002, 51 : A35 - A35
  • [39] A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes
    Stocker, Derek J.
    Taylor, Allen J.
    Langley, Roy W.
    Jezior, Mattliew R.
    Vigersky, Robert A.
    AMERICAN HEART JOURNAL, 2007, 153 (03) : 445.e1 - 445.e6
  • [40] Renal Function in Type 2 Diabetes with Rosiglitazone, Metformin, and Glyburide Monotherapy
    Lachin, John M.
    Viberti, Giancarlo
    Zinman, Bernard
    Haffner, Steven M.
    Aftring, R. Paul
    Paul, Gitanjali
    Kravitz, Barbara G.
    Herman, William H.
    Holman, Rury R.
    Kahn, Steven E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (05): : 1032 - 1040
12345